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Introduction: Miyoshi myopathy, a type of distal myopathy with predominant involvement of the posterior calf
muscles, has been assigned to mutations in the dysferlin gene. However, many of the late-onset limb-girdle and
distal myopathies that resemble dysferlinopathy or Miyoshi myopathy remain unclassified, even after extensive
immunohistological and genetic analysis.
Case presentation: We report the case of a 59-year-old Caucasian man with distal myopathy and exercise-induced
myalgia, preferentially of the leg muscles, closely resembling the Miyoshi phenotype. Magnetic resonance imaging
of his calf muscles showed typical fatty replacement of the medial heads of the gastrocnemius muscles and soleus
muscles, with progression to the adductor longus muscles over a time course of two years. However, genetic
analysis revealed that the phenotype of our patient was not related to a mutation in the dysferlin gene but to a
novel homozygous splice mutation in the anoctamin 5 gene. Mutations in the anoctamin 5 gene have so far been
identified only in some cases of limb-girdle and distal myopathy. Mutations in the anoctamin 5 gene have been
assigned to limb-girdle muscular dystrophy type 2L, while distal Miyoshi-like phenotypes have been classified as
Miyoshi myopathy type 3.
Conclusion: The case presented in this report further strengthens the underlying genetic heterogeneity in Miyoshi
myopathy-like phenotypes and adds another family to non-dysferlin, Miyoshi myopathy type 3 of late-onset.
Furthermore, our case supports the recent observation that anoctamin 5 mutations are a primary cause of distal
non-dysferlin myopathies. Therefore, given the increasing number of anoctamin 5 mutations in Miyoshi-like
phenotypes, genetic analysis should include an anoctamin 5 screen in late-onset limb-girdle and distal myopathies.Introduction
Miyoshi myopathy (MM) is caused by autosomal reces-
sive mutations in the human dysferlin gene [1,2]. In
MM, involvement of the gastrocnemius and soleus
muscles with difficulties in standing on tip toes is char-
acteristic. Clinical signs usually occur in the late teens
and mostly before the age of 30 years. According to its
clinical and histopathological presentation, MM has
been categorized as distal myopathy with typical findings
of muscular dystrophy [3,4].
Late-onset forms of distal muscular dystrophies with
features of MM have been described. These rare cases
with disease onset after the age of 30 years [5] have not* Correspondence: cneusch@gwdg.de
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reproduction in any medium, provided the oronly been attributed to mutations in the dysferlin gene but
have also been described in patients with normal dysferlin
expression [5]. These reports have suggested other genetic
defects causing the MM. Recently, recessive mutations in
the anoctamin 5 (ANO5) gene were identified as the cause
of predominantly asymmetric limb-girdle muscular dys-
trophy (LGMD type 2L) as well as distal myopathies of the
MM phenotype (MMD3) [6,7]. The protein ANO5 is
coded by exons 1 to 22 of the ANO5/TMEM16E gene
located on chromosome 11p14.3. The ANO5 gene
encodes a putative calcium-related chloride channel; how-
ever, the precise function of ANO5 is unknown.Case presentation
A 59-year-old Caucasian man was admitted to hospital
with slowly progressive muscle weakness and wasting ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Photographs and magnetic resonance imaging scans
of the patient’s legs. (A,B) Photographs taken of patient’s legs.
Note muscle wasting that predominantly affects posterior calf
muscles (A). (C) Magnetic resonance images of both calves (top: T1-
weighted image; middle: T1-weighted image, contrast enhanced, fat
suppressed; bottom: Short T1 inversion recovery (STIR) images). Fatty
degeneration of the medial heads of the gastrocnemius muscles
(arrows). Additional areas of edema and contrast enhancement in
the lateral head of the gastrocnemius muscle indicate muscle
inflammation (arrowhead).
Neusch et al. Journal of Medical Case Reports 2012, 6:345 Page 2 of 4
http://www.jmedicalcasereports.com/content/6/1/345his posterior calf muscles. Neurological examination
revealed normal cranial nerve function and intellectual
status. Manual muscle testing showed weakness of Med-
ical Research Council (MRC) grade 4+ out of 5 in his
posterior calf muscles and marginal weakness MRC
grade 5- out of 5 in his anterior calf muscles. His deep
tendon reflexes were symmetrically preserved. His family
history was suggestive for an autosomal recessive trait.
Serum creatine kinase values were normal in our
patient’s two children and one sibling.
On magnetic resonance imaging, T1-weighted turbo
spin echo and short T1 inversion recovery (fat-
suppressed) sequences revealed selective atrophy and
fatty replacement of the medial heads of his gastrocne-
mius muscles and soleus muscles (Figure 1). In follow-
up magnetic resonance imaging two years later, this was
also visible in his adductor longus muscles (not shown).
Contrast-enhanced images showed areas of fatty degen-
eration next to areas with contrast enhancement and
edema in the lateral head of his gastrocnemius muscles
and the proximal part of his soleus muscles.
Needle electromyography of both gastrocnemius mus-
cles showed sparse positive sharp waves. At voluntary
effort, early recruitment of short and small motor unit
action potentials compatible with a myopathic pattern
was observed. Nerve conduction studies revealed normal
sensory nerve action potentials and conduction velocities
of his right median and sural nerve as well as normal
compound muscle action potential amplitudes and nerve
conduction velocities in his right median and tibial
nerve. His serum creatine kinase level was markedly ele-
vated up to 1700U/L (normal, less than 270U/L); lactate
dehydrogenase, 264U/L (normal, less than 232U/L); ala-
nine aminotransferase, 53U/L (normal, less than 35U/L);
and aspartate aminotransferase, 67U/L (normal, less
than 45U/L). His gamma-glutamyl-transpeptidase level
was normal.
Hematoxylin and eosin staining of serial frozen sections
of his gastrocnemius muscle revealed characteristic myo-
pathic changes including marked variation in fiber size,
centrally localized nuclei, and necrotic and regenerating
fibers. Furthermore, moderate endomysial fibrosis as well
as some small perivascular inflammatory infiltrates was
observed (Figure 2). Immunohistochemical stainings were
performed with antibodies against dystrophin (Dys1 and
Dys3), γ- and δ-sarcoglycan, vimentin, desmin, dysferlin
(all from Novocastra, Berlin, Germany), Dys2, spectrin II,
utrophin, α- and β-sarcoglycan, α- and β-dystroglycan (all
from Medac, Wedel, Germany), NCL-merosin (Chemicon,
Temecula, CA, USA), laminin α5 and laminin β1 (Invitro-
gen, Grand Island, NY, USA), actin (Dako, Glostrup, Den-
mark), and caveolin 3 (Dianova, Hamburg, Germany).
Dysferlin immunoreactivity was markedly reduced at mus-
cle fiber membranes but diffusely increased in thecytoplasm of many fibers (Figure 2B). Utrophin expression
was slightly upregulated (data not shown). Immunoblot
analysis was performed using a mini-Protean II Western
blotting system (BioRad, Herts, UK). Immunoblotting ana-
lysis did not reveal any significant reduction of dysferlin
(Figure 2C), dystrophin or calpain 3 (data not shown).
Molecular genetic analyses were performed after
obtaining informed consent from our patient. DNA
extraction and direct sequencing of the complete dysfer-
lin gene was done as described previously [8]. Molecular
genetic analysis of fukutin-related protein, β-sarcoglycan,
calpain-3 and caveolin-3, a putative interaction and
membrane targeting partner of dysferlin, and multiplex
Figure 2 Immunohistochemistry, immunoblotting and molecular genetic analysis. (A) Micrograph of the muscle biopsy of the right
gastrocnemius muscle showing markedly increased variation in fiber size, fiber splitting, increased number of internal nuclei, some very atrophic
fibers, and proliferation of adipose and fibrous tissue (hematoxylin and eosin staining, ×100). (B) Dysferlin labeling of the muscle specimen.
Arrows point to fibers with diffuse and partly granular cytoplasmic dysferlin accumulation. Arrowheads indicate exemplary fibers with remaining
patchy dysferlin signal of the fiber sarcolemma while most fibers completely lack sarcolemmal dysferlin. Bar = 100μM. (C) Immunoblot on muscle
lysates from the patient and two controls showing comparable protein expression levels. (D) Sequencing electropherogram of partial anoctamin
5 exon 8 and intron 8 sequences reveals a novel splice-site mutation at intron 8 that may result in skipping of exon 9.
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dystrophin gene (MRC Holland, Amsterdam, The Neth-
erlands) ruled out underlying mutations with high prob-
ability. Finally, a novel homozygous splice mutation,
c.762 + 5G > T, in the ANO5 gene was identified after
direct Sanger sequencing of all coding exons of ANO5
(Reference sequence NM_ 213599.2). Splice prediction
programs (Alamut mutation prediction program, version
2.1, Interactive Biosoftware, Rouen, France) showed a
loss of the splice donor site. Whilst we could not deter-
mine the impact of this mutation at the protein level it
is suggested that exon 9 could be skipped due to the
identified splice donor site mutation in intron 8.
Discussion
We report an MM-like phenotype caused by a homozy-
gous IVS 8, c.762 + 5G > T mutation in the ANO5 gene.
In some previous cases of late-onset distal myopathies
with predominant involvement of the posterior calf mus-
cles, immunoblotting showed reduced dysferlin levels,
although no dysferlin gene mutation could be found [9].
Other groups described patients with early-onset and
late-onset distal myopathies preferentially involving the
calf muscles who had normal dysferlin expression [5].
Thus it became clear that the phenotype of distal myo-
pathy with predominant involvement of the posterior
calf muscles is not restricted to MMD1 (the MM type of
dysferlinopathy). So far, only a few patients with the
Miyoshi-like phenotype caused by an ANO5 mutation
have been described [6,7]. The manifestation of a limb-
girdle type of myopathy seems to be much morefrequent in ANO5 mutations (LGMD type 2L) [6,10]. In
most cases, asymmetric involvement of proximal or dis-
tal muscles was observed. In contrast with these early
observations in ANO5 mutations, our patient showed
symmetric weakness and wasting of calf muscles which
is the clinical hallmark of MMD3. As in our case, myal-
gia appears to be a typical symptom in ANO5-related
myopathies [6].
Conclusion
We present a case of a patient with late-onset, non-
dysferlin MM with an underlying, novel splice mutation
in ANO5. Our observation enlarges the spectrum of
MM-like myopathies caused by an ANO5 mutation and
further strengthens the underlying genetic heterogeneity
of the MM-like muscle diseases, especially in late-onset
phenotypes. The mutation described here is associated
with reduced sarcolemmal dysferlin and granular cyto-
plasmic dysferlin accumulation on immunohistochemis-
try while dysferlin immunoblot shows equal protein
levels to controls. It remains to be proven whether other
types of anoctaminopathies also show this pattern of
dysferlin expression. For the moment, our findings imply
that dysferlin-staining abnormalities, as in our case,
could give a diagnostic hint to look for an ANO5 muta-
tion and that some pathomechanisms could be linked to
altered dysferlin distribution.
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